Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.
Adam L. Halberstadt, Mark A. Geyer
Neuropharmacology February 1, 2014 DOI: 10.1016/j.neuropharm.2013.08.025 via PubMed
Summary
AI-generated from the abstractN-benzyl substitution greatly increases the potency of phenethylamine hallucinogens at the 5-HT(2A) receptor. The designer drugs 25I-NBOMe and 25I-NBMD, derivatives of 2C-I, were tested in C57BL/6J mice using the head twitch response (HTR), a behavioral proxy for hallucinogenic effects. 2C-I (1-10 mg/kg), 25I-NBOMe (0.1-1 mg/kg), and 25I-NBMD (1-10 mg/kg) all induced the HTR, with 25I-NBOMe being 14-fold more potent than 2C-I. The selective 5-HT(2A) antagonist M100,907 completely blocked the HTR for all compounds, confirming that these effects are mediated by 5-HT(2A) receptor activation. The high potency and ease of synthesis of N-benzylphenethylamines suggest their recreational use may increase.
Study at a glance
| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | C57BL/6J mice |
| Interventions | 2C-I 25I-NBOMe 25I-NBMD M100 907 |
| Dose | 2C-I (1-10 mg/kg SC), 25I-NBOMe (0.1-1 mg/kg SC), 25I-NBMD (1-10 mg/kg SC) |
| Topics | LSD |
| Keywords | Psychedelic pharmacology 5-ht2a receptor activation Head twitch response |
| Citations | 113 |
| Key finding | 25I-NBOMe is 14-fold more potent than 2C-I in inducing the head twitch response via 5-HT(2A) receptor activation in mice. |
Abstract
N-benzyl substitution markedly enhances the affinity of phenethylamine hallucinogens at the 5-HT(2A) receptor. N-benzyl substituted derivatives of 2,5-dimethoxy-4-iodophenethylamine (2C-I), such as N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBOMe) and N-(2,3-methylenedioxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBMD), have appeared recently as designer drugs, but have not been characterized behaviorally. The head twitch response (HTR) is induced by 5-HT(2A) receptor activation in rats and mice, and is widely used as a behavioral proxy for hallucinogen effects in humans. Nevertheless, it is not clear whether phenethylamine hallucinogens reliably provoke this behavior. Hence, we investigated whether 2C-I, 25I-NBOMe and 25I-NBMD induce head twitches in C57BL/6J mice. The HTR was assessed using a head-mounted magnet and a magnetometer coil. 2C-I (1-10 mg/kg SC), 25I-NBOMe (0.1-1 mg/kg SC), and 25I-NBMD (1-10 mg/kg SC) induced the HTR. 25I-NBOMe displayed 14-fold higher potency than 2C-I, and the selective 5-HT(2A) antagonist M100,907 completely blocked the HTR induced by all three compounds. These findings show that phenethylamine hallucinogens induce the HTR by activating 5-HT(2A) receptors. Our results demonstrate that 25I-NBOMe is a highly potent derivative of 2C-I, confirming previous in vitro findings that N-benzyl substitution increases 5-HT(2A) affinity. Given the high potency and ease of synthesis of N-benzylphenethylamines, it is likely that the recreational use of these hallucinogens will become more widespread in the future.